Literature DB >> 6716223

Pulmonary vascular disease in fatal meconium aspiration.

J D Murphy, G F Vawter, L M Reid.   

Abstract

Although not proved, it is generally accepted that pulmonary vasospasm is responsible for the persistent pulmonary hypertension frequently associated with meconium aspiration. We have studied the pulmonary vasculature in 11 consecutive infants with fatal meconium aspiration, applying morphometric techniques to pulmonary arteries distended with barium gelatin before fixation. In 10 of the 11 infants, persistent pulmonary hypertension was evident clinically, with right-to-left shunting through the foramen ovale or ductus arteriosus. In all but one, severe structural abnormal muscularization of the smallest intra-acinar arteries was present. These changes must have developed before birth. In only one infant was the structure of the intra-acinar precapillary arteries virtually normal, as would be expected if vasospasm alone had caused the hypertension. The persistent pulmonary hypertension associated with fatal meconium aspiration may be the result of a structurally abnormal pulmonary microcirculation.

Entities:  

Mesh:

Year:  1984        PMID: 6716223     DOI: 10.1016/s0022-3476(84)80962-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

Review 1.  Fetal monitoring and neonatal resuscitation: what the anaesthetist should know.

Authors:  J Guay
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

2.  Appraisal of Meconium at Delivery: A look at intervention strategies.

Authors:  B A Paes; P Thompson
Journal:  Can Fam Physician       Date:  1992-09       Impact factor: 3.275

Review 3.  The Robyn Barst Memorial Lecture: Differences between the fetal, newborn, and adult pulmonary circulations: relevance for age-specific therapies (2013 Grover Conference series).

Authors:  Steven H Abman; Christopher Baker; Jason Gien; Peter Mourani; Csaba Galambos
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

Review 4.  Role of reactive oxygen species in neonatal pulmonary vascular disease.

Authors:  Stephen Wedgwood; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

5.  Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling.

Authors:  Namasivayam Ambalavanan; Arlene Bulger; Joanne Murphy-Ullrich; Suzanne Oparil; Yiu-Fai Chen
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

6.  Pulmonary Hypertension Associated with Hypoxic-Ischemic Encephalopathy-Antecedent Characteristics and Comorbidities.

Authors:  Satyan Lakshminrusimha; Seetha Shankaran; Abbot Laptook; Scott McDonald; Martin Keszler; Krisa Van Meurs; Ronnie Guillet; Sanjay Chawla; Beena G Sood; Sonia Bonifacio; Abhik Das; Rosemary D Higgins
Journal:  J Pediatr       Date:  2018-03-01       Impact factor: 4.406

7.  Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach?

Authors:  Praveen Chandrasekharan; Rafal Kozielski; Vasantha H S Kumar; Munmun Rawat; Veena Manja; Changxing Ma; Satyan Lakshminrusimha
Journal:  Am J Perinatol       Date:  2016-09-14       Impact factor: 1.862

8.  Pulmonary vasculature changes associated with idiopathic closure of the ductus arteriosus and hydrops fetalis.

Authors:  G J Downing; D W Thibeault
Journal:  Pediatr Cardiol       Date:  1994 Mar-Apr       Impact factor: 1.655

9.  Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn.

Authors:  Cassidy Delaney; Jason Gien; Gates Roe; Nicole Isenberg; Jenai Kailey; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-19       Impact factor: 5.464

10.  Morphometric analysis of the lung vasculature after extracorporeal membrane oxygenation treatment for pulmonary hypertension in newborns.

Authors:  Arno van Heijst; Remco Haasdijk; Freek Groenman; Frans van der Staak; Christina Hulsbergen-van de Kaa; Ronald de Krijger; Dick Tibboel
Journal:  Virchows Arch       Date:  2004-06-03       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.